Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

DRTS vs IRMD: stock comparison and AI forecast

Alpha Tau Medical Ltd. (DRTS) and Iradimed Corp (IRMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Surgical & Medical Instruments & Apparatus

DRTS Alpha Tau Medical Ltd.

Price
$13.30 +69.4% · 6M
Market Cap
$1.17B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Surgical & Medical Instruments & Apparatus

IRMD Iradimed Corp

Price
$86.31 -0.5% · 6M
Market Cap
$1.10B
P/E Ratio
47.2x
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-07 → 2026-11-06

Six-month price performance

Closing prices rebased to 100 at the start of the window.

100125150175200
DRTS +69.4% IRMD -0.5%
DRTS · IRMD

Key facts

  • DRTS and IRMD have similar market capitalizations ($1.17B and $1.10B).
  • Over the last six months DRTS returned +69.4% and IRMD -0.5%.
  • DRTS carries 0.37 times debt per unit of equity, against 0.14 times for IRMD.
  • IRMD yields 1.47% in dividends; DRTS pays none.
  • Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricDRTSIRMD
Market Cap$1.17B$1.10B
P/E Ratio–47.16x
P/B Ratio15.18x10.37x
Dividend Yield–1.47%
EPS$-0.98$1.83
Book Value/Share$0.88$8.32
Revenue/Share–$6.99
FCF/Share–$2.04

Profitability & Margins

MetricDRTSIRMD
ROE-96.5%22.5%
ROA-70.4%19.8%
ROIC-82.3%26.1%
Gross Margin–75.5%
Operating Margin–32.3%
Net Margin–26.9%
EBT Margin–34.8%
Tax Rate-0.2%22.9%

Financial Health

MetricDRTSIRMD
Current Ratio7.45x8.99x
Quick Ratio–7.68x
D/E Ratio0.37x0.14x
Financial Leverage1.37x1.14x
Interest Coverage-95.6x–
Working Capital$68M$82M

Cash Flow

MetricDRTSIRMD
Operating Cash Flow-$46M$27M
Free Cash Flow–$26M
Capital Spending–-$1M
OCF Growth YoY–8.6%
FCF Growth YoY–77.2%
FCF/Sales–29.3%
CapEx/Sales–1.1%

Operational Efficiency

MetricDRTSIRMD
Asset Turnover–0.74x
Receivables Turnover–6.5x
Inventory Turnover–1.6x
Fixed Assets Turnover–3.7x
Days Sales Outstanding–56 days
Days Inventory–225 days
Payables Period–40 days
Cash Conversion Cycle–241 days

Income Statement

MetricDRTSIRMD
Total Revenue–$89M
Operating Income-$78M$29M
Net Income-$74M$24M
R&D Expense$59M$3M
SG&A Expense–$41M
Cost of Goods Sold–$22M

Dividend & Shareholder Information

MetricDRTSIRMD
Dividends Per Share–$1.27
Payout Ratio–69.4%
Shares Outstanding88M13M
Net Income Growth–10.0%
EPS Growth–19.6%
FAQ

DRTS vs IRMD: stock comparison and AI forecast

Which is bigger, DRTS or IRMD?

DRTS and IRMD have similar market capitalizations ($1.17B and $1.10B).

Which stock performed better over the last six months, DRTS or IRMD?

Over the last six months DRTS returned +69.4% and IRMD -0.5%.

Which one does Intratio's AI model rank higher, DRTS or IRMD?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.